patent/UA-105211-C2

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-105211-C2

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f834ce5e3653300cfeee6fc9f68468f7
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
filingDate	2010-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e980f0e7a63117ae740658936c938a10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_762d448965b097cfcf56c62389fa7619 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef179148d930e338e6b54d981e88ba3b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28fddfdfe160373d0f724bf886875176 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddfa699c4ec996fcfd1daca49509d4ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe4c656eb6e751be5c51d2e193a771d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9d469e25b25305f43defbfe477456ee
publicationDate	2014-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	UA-105211-C2
titleOfInvention	CHINOXALINE DERIVATIVES AND THEIR APPLICATION FOR TREATMENT OF BENEFIT AND MALIGNANT TUMOR DISEASES
abstract	In accordance with the present invention, quinoxalines of general formula I are proposed to be used as medicaments for the treatment of tumor diseases, in particular in cases of resistance to other active compounds or in cases of metastatic carcinoma. Possible applications are not limited to tumor diseases.
priorityDate	2009-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457489092

Total number of triples: 33.